Fundraising FoxInvoke Bio
1 known investors
Find your way into Invoke Bio
Sign up to see every warm intro you have to Invoke Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Invoke Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.
Founders & leadership
LF
Luke ForsthoefelCo-Founder & Chief Business OfficerLuke Forsthoefel is co-founder and chief business officer at Invoke Bio, which develops personalized cancer treatments using neoantigen prediction models. He previously worked in strategy consulting for early-stage and multinational biopharma companies and in investment banking for technology companies, where he focused on commercialization strategy and product launches.
Investors · 1
Frequently asked questions
- What does Invoke Bio do?
- Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.
- Who founded Invoke Bio?
- Invoke Bio was founded by TJ Sears, Luke Forsthoefel.
- Who are Invoke Bio's investors?
- Invoke Bio's investors include HCVC.